Detalles de la búsqueda
1.
Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.
Br J Haematol
; 204(3): 892-897, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38013238
2.
Acquired erythropoietic uroporphyria secondary to myeloid malignancy: A case report and literature review.
Photodermatol Photoimmunol Photomed
; 38(1): 86-91, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34319628
3.
Infrequent Presentations of Chronic NPM1-Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature.
Cancers (Basel)
; 16(4)2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38398096
4.
Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome.
Blood Adv
; 7(19): 5799-5811, 2023 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37450374
5.
Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes.
Cancers (Basel)
; 14(17)2022 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077644
6.
Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan.
Bone Marrow Transplant
; 57(8): 1304-1312, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35643942
7.
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol.
Blood Adv
; 6(4): 1193-1206, 2022 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34911079
8.
Risk Factors for Mortality in Hematopoietic Stem Cell Transplantation Recipients with Bloodstream Infection: Points To Be Addressed by Future Guidelines.
Transplant Cell Ther
; 27(6): 501.e1-501.e6, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33891882
9.
The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever.
PLoS One
; 15(11): e0241778, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33147257
10.
Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBF.
Leuk Res
; 135: 107403, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37837718
11.
Safety of COVID-19 vaccination in patients with clonal mast cell disorders.
J Allergy Clin Immunol Pract
; 10(5): 1374-1376.e3, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35121156
Resultados
1 -
11
de 11
1
Próxima >
>>